3Jada AR, Moore A, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary. Control Clin Trails 1996;17:1 - 12.
4Kaufman HS, Roth HL. Hyposensitization with alum precipitated extracts in atopic dermatitis: a placebo controlled study. Ann Allergy 1974;32:321 - 330.
5Glover MT, Atherton DJ. A double, blind controlled trial of hypo- sensitization to Dermatophagoides ptemnyssinus in children with atopic eczema. Clin Exp Allergym Apr 1992;22(4):440- 446.
6Silny W, Czarnecka- Operacz M. Specific immunotherapy in the treatment of patients with atopic dermatitis - results of double blind placebo controlled study. Pol Merkur Lekarski 2006; 21 (126) : 558 - 565.
7Werfel T, Breuer K, Rueff F, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi - centre, randomized, dose - response study. Allergy 2006;61(2) :202- 205.
8Pajno GB, Caminiti L, Vita D, et al. Sublingual immunothempy in mite- sensitized children with atopic dermatitis: a randomized, double- blind, placebo- controlled study. J Allergy CAin Immunol 21307; 120(1) : 164 - 170.
9Samochocki Z, Rudzki. Desuhs of desensitization using household dust mite in patients with atopic dermatitis. Przegl Dermtol 1990; 77(2) : 132 - 136.
10Wen T(温廷桓), WarLg E. Allergic potency of SMU - Df extract in comparison with VUS -Df extract; and diagnosis and immunotherapy for atopic dermatitis and rhinitis with SMU- Df extract in China. Arb Paul Ehrhch Inst Bundesamt Sera Impfstoffe Frankf Am 1992; 85:217 - 227.
